论文部分内容阅读
本文应用瑞典制造的phadebas β_2-micro test对112例消化系统良性及恶性疾病用RIA法测定血清β_2微球蛋白的结果,包括28例慢性肝炎、16例失代偿期肝硬化(11例为肝炎后肝硬化)、12例食管癌、37例进展性胃癌、3例结肠癌、10例原发性肝癌以及胰腺癌和胆囊癌各3例。 由试验药盒提供的183例正常人β_2m正常值<3.0μg/ml;慢性肝炎患者均值为2.65±2.89μg/ml,与
The results of serum β 2 microglobulin determination in 112 patients with benign and malignant diseases of the digestive system were measured by the Swedish-made phadebas β 2 -micro test, including 28 cases of chronic hepatitis and 16 cases of decompensated liver cirrhosis (11 cases of hepatitis Post cirrhosis), 12 cases of esophageal cancer, 37 cases of advanced gastric cancer, 3 cases of colon cancer, 10 cases of primary liver cancer, and 3 cases of pancreatic and gallbladder cancer. The normal value of β 2 m in the 183 normal subjects provided by the test kit was <3.0 μg/ml; the mean value of patients with chronic hepatitis was 2.65±2.89 μg/ml.